TransMedics Group, Inc. - Laporan Laba Rugi (TTM)

TransMedics Group, Inc.
US ˙ NasdaqGM ˙ US89377M1099

Laporan Laba Rugi (TTM)

Laporan Laba Rugi TransMedics Group, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 24 26 25 30 28 30 39 51 72 93 119 151 192 242 297 359 401 442 488 531
Change (%) 6.52 -1.86 19.00 -5.75 7.23 29.17 31.59 39.49 30.25 27.47 26.81 26.97 25.96 22.89 20.83 11.80 10.09 10.57 8.82
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 9 9 9 10 9 9 11 14 20 28 37 47 65 88 112 141 163 179 198 214
Change (%) 5.67 -4.75 12.83 -4.71 -1.27 16.85 33.74 41.97 39.56 31.97 25.68 38.93 34.76 27.53 26.27 15.71 10.03 10.26 7.95
% of Revenue 35.40 35.12 34.08 32.32 32.67 30.08 27.21 27.66 28.15 30.16 31.22 30.95 33.86 36.23 37.60 39.29 40.66 40.64 40.53 40.21
Gross Operating Profit 16 17 17 20 19 21 28 37 52 65 82 104 127 154 185 218 238 262 290 318
Change (%) 6.99 -0.29 22.19 -6.24 11.36 34.47 30.79 38.54 26.61 25.53 27.33 21.61 21.46 20.24 17.55 9.27 10.12 10.79 9.41
% of Revenue 64.60 64.88 65.92 67.68 67.33 69.92 72.79 72.34 71.85 69.84 68.78 69.05 66.14 63.77 62.40 60.71 59.34 59.36 59.47 59.79
SG&A 24 24 24 28 32 38 45 54 60 70 81 93 107 118 129 142 154 169 176 177
Change (%) 0.01 0.55 13.55 17.53 17.94 18.68 18.09 12.14 16.16 15.80 14.79 14.85 10.15 9.51 10.52 8.44 9.30 4.43 0.68
% of Revenue 100.48 94.34 96.66 92.23 115.02 126.51 116.24 104.31 83.86 74.79 67.94 61.50 55.63 48.65 43.36 39.66 38.46 38.19 36.07 33.37
R&D 21 19 17 20 21 22 25 26 27 27 25 27 31 36 42 47 50 56 62 64
Change (%) -8.34 -8.99 13.96 5.16 8.60 13.46 1.66 6.39 -2.04 -6.20 6.27 16.18 16.12 15.28 13.39 6.65 11.35 10.33 3.36
% of Revenue 85.36 73.45 68.11 65.23 72.78 73.70 64.74 50.01 38.15 28.69 21.11 17.69 16.19 14.92 14.00 13.14 12.53 12.68 12.65 12.01
OpEx 53 52 50 57 62 70 81 94 108 125 143 166 203 241 282 330 368 404 436 455
Change (%) -2.31 -3.82 13.56 9.49 12.01 16.77 15.02 15.10 15.93 14.73 16.12 21.83 18.95 16.91 17.18 11.29 9.90 7.84 4.36
% of Revenue 221.24 202.91 198.86 189.78 220.46 230.29 208.19 181.97 150.15 133.64 120.28 110.14 105.68 99.80 94.95 92.08 91.66 91.51 89.24 85.59
Operating Income -29 -26 -25 -27 -34 -39 -42 -42 -36 -31 -24 -15 -11 0 15 28 33 37 53 77
Change (%) -9.59 -5.72 8.07 26.47 15.98 7.26 -0.29 -14.66 -12.64 -23.16 -36.59 -28.86 -104.45 2,991.75 89.46 17.76 12.08 40.06 45.81
% of Revenue -121.24 -102.91 -98.86 -89.78 -120.46 -130.29 -108.19 -81.97 -50.15 -33.64 -20.28 -10.14 -5.68 0.20 5.05 7.92 8.34 8.49 10.76 14.41
Interest Expense -4 -4 -4 -4 -4 -4 -4 -4 -4 -4 -4 -5 -8 -11 -13 -14 -14 -14 -14 -14
Change (%) -2.26 -2.26 -0.92 0.21 0.18 0.21 0.18 -4.94 0.78 3.52 39.75 52.00 31.71 23.23 8.41 0.19 -0.24 -0.95 -1.03
% of Revenue -16.94 -15.54 -15.48 -12.89 -13.70 -12.80 -9.93 -7.56 -5.15 -3.99 -3.24 -3.57 -4.27 -4.47 -4.48 -4.02 -3.60 -3.26 -2.92 -2.66
Net Income -32 -29 -28 -30 -38 -44 -47 -48 -42 -36 -28 -18 -36 -25 -10 3 33 35 49 72
Change (%) -9.07 -3.25 7.81 26.26 16.79 5.98 1.82 -11.60 -14.10 -21.88 -37.17 101.20 -30.05 -59.27 -129.43 987.93 8.66 38.02 46.40
% of Revenue -131.35 -112.13 -110.54 -100.14 -134.15 -146.11 -119.88 -92.76 -58.78 -38.77 -23.76 -11.77 -18.65 -10.36 -3.43 0.84 8.14 8.03 10.03 13.49

Source: Capital IQ

Other Listings
MX:TMDX
DE:8T8
IT:1TMDX € 103.10
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista